Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HASPIN | Q8TF76 | 12/20 | 0.41 |
| ▸ | PIM1 | P11309 | 4/20 | 0.38 |
| ▸ | CCNT1 | O60563 | 4/20 | 0.38 |
| ▸ | CDK9 | P50750 | 4/20 | 0.38 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.38 |
| ▸ | CLK1 | P49759 | 2/20 | 0.37 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.36 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.34 |
| ▸ | PRKCI | P41743 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | IKBKB | O14920 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26423346 | 1.00 | HASPIN (0.41) | HASPINPIM1CCNT1CDK9MKNK2 | |
| SCHEMBL26423219 | 0.87 | EGFR (0.39) | GRM4 | |
| SCHEMBL26423242 | 0.81 | KDM4E (0.44) | HASPINPIM1CCNT1CDK9CLK1 | |
| SCHEMBL26423245 | 0.81 | KDM4E (0.44) | HASPINPIM1CCNT1CDK9CLK1 | |
| SCHEMBL26423439 | 0.81 | EGFR (0.39) | — | |
| SCHEMBL26423441 | 0.81 | EGFR (0.39) | — | |
| SCHEMBL26423264 | 0.80 | HASPIN (0.41) | HASPINPIM1CCNT1CDK9CLK1 | |
| SCHEMBL26423262 | 0.80 | HASPIN (0.41) | HASPINPIM1CCNT1CDK9CLK1 | |
| SCHEMBL26423357 | 0.80 | HASPIN (0.40) | HASPINPIM1CCNT1CDK9MKNK2 | |
| SCHEMBL26423359 | 0.80 | HASPIN (0.40) | HASPINPIM1CCNT1CDK9MKNK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230127291-A1 | HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127291-A1 | HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL | OCIAD2, OCIAD1, AZI2 | HASPIN 2934/4885PIM1 3895/4885CCNT1 561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.